mRNA Vaccines Enhance Neutralizing Immunity against SARS-CoV-2 Variants in Convalescent and ChAdOx1-Primed Subjects
To identify the most efficient methods of immunological protection against SARS-CoV-2, including the currently most widespread variants of concern (VOCs)—B.1.1.7, B.1.351 and P.1—a simultaneous side-by-side-comparison of available vaccination regimes is required. In this observational cohort study,...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
格式: | 文件 |
语言: | English |
出版: |
MDPI AG
2021-08-01
|
丛编: | Vaccines |
主题: | |
在线阅读: | https://www.mdpi.com/2076-393X/9/8/918 |